114 related articles for article (PubMed ID: 10215102)
1. Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma.
Cetin M; Demirci D; Unal A; Altinbaş M; Güven M; Unlühizarci K
Hum Exp Toxicol; 1999 Mar; 18(3):137-40. PubMed ID: 10215102
[TBL] [Abstract][Full Text] [Related]
2. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
[TBL] [Abstract][Full Text] [Related]
3. Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
Lin AD; Chen KK; Lin AT; Chang YH; Wu HH; Kuo JY; Huang WJ; Hsu YS; Chung HJ; Chang LS
J Chin Med Assoc; 2003 Dec; 66(12):735-40. PubMed ID: 15015823
[TBL] [Abstract][Full Text] [Related]
4. Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
Rosenthal SA; Linstadt DE; Leibenhaut MH; Andras EJ; Brooks CP; Stickney DR; Chang GC; Wolkov HB; Gilbert RM
Radiology; 1996 May; 199(2):451-5. PubMed ID: 8668793
[TBL] [Abstract][Full Text] [Related]
5. [Changes in liver function induced by flutamide in patients with prostate cancer (studies in patients treated with total androgen blockage)].
Ikemoto I; Ohishi Y; Yamazaki H; Wada T; Aizawa Y
Nihon Hinyokika Gakkai Zasshi; 2000 Jun; 91(6):556-61. PubMed ID: 10897581
[TBL] [Abstract][Full Text] [Related]
6. [Toxic hepatitis and liver failure under therapy with flutamide].
Lübbert C; Wiese M; Haupt R; Ruf BR
Internist (Berl); 2004 Mar; 45(3):333-40. PubMed ID: 14997310
[TBL] [Abstract][Full Text] [Related]
7. Flutamide-induced hepatotoxicity: report of a case series.
García Cortés M; Andrade RJ; Lucena MI; Sánchez Martínez H; Fernández MC; Ferrer T; Martín-Vivaldi R; Peláez G; Suárez F; Romero-Gómez M; Montero JL; Fraga E; Camargo R; Alcántara R; Pizarro MA; García-Ruiz E; Rosemary-Gómez M
Rev Esp Enferm Dig; 2001 Jul; 93(7):423-32. PubMed ID: 11685939
[TBL] [Abstract][Full Text] [Related]
8. Flutamide hepatotoxicity.
Wysowski DK; Fourcroy JL
J Urol; 1996 Jan; 155(1):209-12. PubMed ID: 7490837
[TBL] [Abstract][Full Text] [Related]
9. [Hepatotoxicity of flutamide].
Wietzke P; Münke H; Hartmann H; Ramadori G
Z Gastroenterol; 1997 Aug; 35(8):631-5. PubMed ID: 9381745
[No Abstract] [Full Text] [Related]
10. [The hepatotoxicity of flutamide].
Pogromov AP; Popova AM
Klin Med (Mosk); 1998; 76(7):56-8. PubMed ID: 9742783
[No Abstract] [Full Text] [Related]
11. Flutamide-induced liver injury: a case report.
Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Huang YS; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):678-82. PubMed ID: 9872026
[TBL] [Abstract][Full Text] [Related]
12. [Flutamide-induced hepatic disorder and serum concentrations of flutamide and its metabolites in patients with prostate cancer].
Nakagawa Y; Koyama M; Matsumoto M
Hinyokika Kiyo; 1999 Dec; 45(12):821-6. PubMed ID: 10659414
[TBL] [Abstract][Full Text] [Related]
13. Flutamide-induced liver toxicity including fatal hepatic necrosis.
Crownover RL; Holland J; Chen A; Krieg R; Young BK; Roach M; Fu KK
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):911-5. PubMed ID: 8598370
[TBL] [Abstract][Full Text] [Related]
14. Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.
Cicognani C; Malavolti M; Morselli-Labate AM; Sama C; Barbara L
Dig Dis Sci; 1996 Nov; 41(11):2219-21. PubMed ID: 8943975
[TBL] [Abstract][Full Text] [Related]
15. Flutamide-induced acute hepatitis in advanced prostate cancer patients.
Kraus I; Vitezic D; Oguic R
Int J Clin Pharmacol Ther; 2001 Sep; 39(9):395-9. PubMed ID: 11563686
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of Danish Prostatic Cancer Group trial 86. Goserelin acetate plus flutamide versus orchiectomy in advanced prostate cancer.
Iversen P; Rasmussen F; Klarskov P; Christensen IJ
Cancer; 1993 Dec; 72(12 Suppl):3851-4. PubMed ID: 8252502
[TBL] [Abstract][Full Text] [Related]
17. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
Scher HI; Kelly WK
J Clin Oncol; 1993 Aug; 11(8):1566-72. PubMed ID: 7687666
[TBL] [Abstract][Full Text] [Related]
18. Fatal and nonfatal hepatotoxicity associated with flutamide.
Wysowski DK; Freiman JP; Tourtelot JB; Horton ML
Ann Intern Med; 1993 Jun; 118(11):860-4. PubMed ID: 7683180
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer].
Patel H; Rhee E; Zimmern PE
J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
